Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
1.
BMC Infect Dis ; 16: 388, 2016 08 09.
Article in English | MEDLINE | ID: mdl-27506202

ABSTRACT

BACKGROUND: Melioidosis caused by Burkholderia pseudomellei is an infection with protean clinical manifestations. Guillain-Barré syndrome [GBS] associated with melioidosis is very rare. CASE PRESENTATION: A 42-year-old woman with diabetes presented with abdominal pain, vomiting and intermittent fever for one month. Six months before presentation she had recurrent skin abscesses. Three months before presentation she had multiple liver abscesses which were aspirated in a local hospital. The aspirate grew "coliforms" resistant to gentamicin and sensitive to ceftazidime. On presentation she had high fever and tender hepatomegaly. Ultra Sound Scan of abdomen showed multiple liver and splenic abscesses. Based on the suggestive history and sensitivity pattern of the previous growth melioidosis was suspected and high dose meropenem was started. Antibodies to melioidin were raised at a titre of 1:10240. The growth from the aspirate of liver abscess was confirmed as Burkholderia pseudomellei by polymerase chain reaction [PCR]. After a week of treatment, patient developed bilateral lower limb weakness. Deep tendon reflexes were absent. There was no sensory loss or bladder/bowel involvement. Analysis of the cerebro-spinal fluid showed elevated proteins with no cells. There was severe peripheral neuropathy with axonal degeneration. A diagnosis of GBS was made and she was treated with plasmapharesis with marked improvement of neurological deficit. Continuation of intravenous antibiotics lead to further clinical improvement with normalization of inflammatory markers and resolution of liver and splenic abscess. Eradication therapy with oral co-trimoxazole and co-amoxyclav was started on the seventh week. Patient was discharged to outpatient clinic with a plan to continue combination of oral antibiotics for 12 weeks. At the end of 12 weeks she was well with complete neurological resolution and no evidence of a relapse. CONCLUSIONS: Guillaine Barre syndrome is a rare complication of melioidosis and should be suspected in a patient with melioidosis who develop lower limb weakness. Plasmapharesis can be successfully used to treat GBS associated with active melioidosis.


Subject(s)
Anti-Bacterial Agents/therapeutic use , Guillain-Barre Syndrome/etiology , Melioidosis/complications , Abdominal Pain/etiology , Administration, Oral , Adult , Amoxicillin-Potassium Clavulanate Combination/therapeutic use , Anti-Bacterial Agents/administration & dosage , Burkholderia pseudomallei/genetics , Burkholderia pseudomallei/pathogenicity , Ceftazidime/therapeutic use , Drug Resistance, Bacterial/drug effects , Female , Gentamicins/therapeutic use , Humans , Injections, Intravenous , Liver Abscess/drug therapy , Liver Abscess/microbiology , Melioidosis/diagnosis , Melioidosis/drug therapy , Meropenem , Peripheral Nervous System Diseases/etiology , Polymerase Chain Reaction , Splenic Diseases/complications , Thienamycins/therapeutic use , Trimethoprim, Sulfamethoxazole Drug Combination/therapeutic use
2.
Case Rep Infect Dis ; 2021: 9893619, 2021.
Article in English | MEDLINE | ID: mdl-34426773

ABSTRACT

[This corrects the article DOI: 10.1155/2021/9989847.].

3.
Case Rep Infect Dis ; 2021: 9989847, 2021.
Article in English | MEDLINE | ID: mdl-34007497

ABSTRACT

Spinal-epidural abscess (SEA) is believed to be primarily of haematogenous origin and very rarely as a consequence of central neuraxial blockade. Early diagnosis and pertinent management invariably improve neurological outcomes. We report a case of long-segment SEA, which was suspected during subarachnoid anaesthesia, subsequently diagnosed and managed appropriately, averting irreversible neurological deficits.

4.
J Med Microbiol ; 68(3): 395-397, 2019 Mar.
Article in English | MEDLINE | ID: mdl-30663952

ABSTRACT

PURPOSE: Polymerase chain reaction (PCR) is increasingly being used to detect enteric pathogens and is currently NICE's recommended practice. We wished to evaluate the performance characteristics of PCR for the detection of salmonella in consecutive stool samples in a real-world setting, compared to the gold standard of enrichment culture. METHODOLOGY: We performed a prospective study over 9 months in which the PCR and culture results for salmonella were scrutinized for all stool samples sent to the laboratory. All stool samples underwent selenite enrichment culture for salmonella with confirmation being obtained using the API 10S and serotyping. Samples also underwent PCR using the BD MAX Enteric Bacterial Panel. The sensitivity and specificity of PCR in detecting salmonella were compared to those of enrichment culture. RESULTS: Six thousand three hundred and seventy-two stool culture and PCR pairs from 5619 patients were analysed. The prevalence of salmonella was found to be 1.2 %. The sensitivity, specificity, positive predictive value and negative predictive value of PCR versus culture were 89 % (67/75), 99.8 % (6286/6297), 86 % (67/78) and 99.9 % (6286/6294), respectively. CONCLUSION: Enrichment culture is significantly more sensitive than PCR using the BD MAX Enteric Bacterial Panel for detecting salmonella in stool. Where PCR testing is used for the detection of enteric pathogens, we recommend that enrichment culture for salmonella be continued in parallel, unless the PCR method is shown to be at least as sensitive as culture.


Subject(s)
Bacteriological Techniques , Feces/microbiology , Polymerase Chain Reaction , Salmonella/isolation & purification , Diarrhea/microbiology , Humans , Molecular Diagnostic Techniques , Predictive Value of Tests , Prospective Studies , Salmonella/genetics , Salmonella/growth & development , Sensitivity and Specificity
SELECTION OF CITATIONS
SEARCH DETAIL